Skip to main content

Table 5 The distribution of HIV-1 DR mutations in RTs coding region among different genotypes

From: HIV-1 drug-resistant mutations and related risk factors among HIV-1-positive individuals experiencing treatment failure in Hebei Province, China

Genotypes

Participants

Reverse transcriptase inhibitor mutations

M184V/I

M41L

T215Y/F/I/N

K70R

D67N

K65R

T69i

L74I/V

K103N/S/T

Y181C

V106A/M

Y188L/C

G190A/S

M230L/I

P225H

CRF01_AE

133

26

2

8

7

7

0

1

0

15

12

0

2

7

1

1

B

139

35

9

12

11

6

3

0

5

23

14

4

3

12

3

3

07-BC

45

3

0

0

0

0

0

0

0

2

0

1

0

0

0

0

C

4

1

0

0

0

0

1

0

0

0

1

0

0

0

0

0

URFs

2

0

0

0

0

0

0

0

0

0

1

0

0

0

0

0

CRF02-AG

2

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

08-BC

7

0

0

0

0

0

0

0

0

0

0

0

0

1

0

0

χ2 test

7.289

F

4.320

4.049

2.398

F

F

6.505

4.889

4.785

F

F

4.714

F

F

P

0.026

0.048

0.115

0.132

0.302

0.367

0.562

0.065

0.087

0.091

0.129

1.000

0.095

0.796

0.796

  1. F Fisher’s exact test, RTs reverse transcriptase inhibitors